Summit Partners Public Asset Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-410,292
Closed -$23.9M – 181
2025
Q1
$23.9M Sell
410,292
-141,475
-26% -$9.7M 0.61% 58
2024
Q4
$44.4M Buy
551,767
+8,721
+2% +$745K 0.85% 43
2024
Q3
$43.5M Sell
543,046
-219,648
-29% -$15.6M 1.35% 27
2024
Q2
$46.6M Sell
762,694
-4,050
-0.5% -$241K 1.78% 22
2024
Q1
$37.9M Buy
766,744
+428,246
+127% +$20.4M 1.3% 28
2023
Q4
$14.2M Buy
+338,498
New +$11.5M 0.59% 70

Other funds holding PRCT

Summit Partners Public Asset Management's PRCT Position: Q2 2025 in Review

Summit Partners Public Asset Management sold out of Procept Biorobotics (PRCT) in Q2 2025, closing a stake of 410,292 shares — an estimated $23.9M sold.

Summit Partners Public Asset Management first reported a position in PRCT in Q4 2023 and held it in 6 quarters. The position peaked at $46.6M in Q2 2024. 274 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • Summit Partners Public Asset Management reported no remaining Procept Biorobotics position as of Q2 2025 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 410,292 Procept Biorobotics shares in Q2 2025, an estimated $23.9M.
  • Summit Partners Public Asset Management first reported a position in Procept Biorobotics in Q4 2023 and held it in 6 quarters.
  • Summit Partners Public Asset Management's Procept Biorobotics position peaked at $46.6M in Q2 2024.
  • 274 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on Summit Partners Public Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.